Loading...
Rising Reimbursement Pressures And Regulatory Hurdles Will Dampen Future Prospects
AnalystLowTarget's Fair Value
US$47.73
24.4% overvalued intrinsic discount24 Aug
US$59.36
1Y
-16.3%7D
3.0%1Y
-16.3%7D
3.0%You can edit this narrative until Aug 24 11:02 PM. Then, changes will post as Updates.